Details of the Drug Combinations

General Information of This Drug (ID: DM8V75C)

Drug Name
ABIRATERONE   DM8V75C
Synonyms Abiraterone (AR inhibitor)
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

997 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Mechlorethamine DCLCQJA Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Mechlorethamine DCQ7VNL Mechlorethamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Pentostatin DCGLYYH Pentostatin Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Pentostatin DCEJEU3 Pentostatin Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Picoplatin DC61VMN Picoplatin Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Fulvestrant DCDG7U9 Fulvestrant Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Fulvestrant DCPB63D Fulvestrant Glioblastoma (Cell Line: SNB-75) [2]
ABIRATERONE + Fulvestrant DCQAS4W Fulvestrant Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Fulvestrant DCGIKHD Fulvestrant Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Gefitinib DCEJMZ9 Gefitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Gefitinib DCGQ7V4 Gefitinib Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Gefitinib DCVQ7MU Gefitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Gefitinib DCKKGN5 Gefitinib Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Gefitinib DCJ0MWD Gefitinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Gefitinib DCTX408 Gefitinib Glioma (Cell Line: SF-539) [2]
ABIRATERONE + Gefitinib DC8TICB Gefitinib Glioma (Cell Line: SF-295) [2]
ABIRATERONE + Gefitinib DCUTS6D Gefitinib Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Ruxolitinib DCDQQQK Ruxolitinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Hepzato DCT68EA Hepzato Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Ixabepilone DCHKAU7 Ixabepilone Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Ixabepilone DC4ZEC1 Ixabepilone Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Ixabepilone DCF80QB Ixabepilone Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Dactinomycin DC6E0NN Dactinomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Dactinomycin DC6FL40 Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Dactinomycin DCTRII7 Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Dactinomycin DCRIQX2 Dactinomycin Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Dactinomycin DCMW7VW Dactinomycin Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Dactinomycin DCK2AMY Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
ABIRATERONE + Dactinomycin DCLDUI4 Dactinomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Dactinomycin DCUOXHX Dactinomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Dactinomycin DCWLS89 Dactinomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Dactinomycin DC0X85H Dactinomycin Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Dactinomycin DCIYNR7 Dactinomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Dactinomycin DCMTQBE Dactinomycin Glioblastoma (Cell Line: SNB-75) [2]
ABIRATERONE + Dactinomycin DCOL5LN Dactinomycin Glioma (Cell Line: SF-539) [2]
ABIRATERONE + Dactinomycin DCNCNX8 Dactinomycin Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Dactinomycin DC7YJ4P Dactinomycin Glioma (Cell Line: SF-295) [2]
ABIRATERONE + Dactinomycin DCH54R8 Dactinomycin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Dactinomycin DC8BDXF Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Dactinomycin DC2I509 Dactinomycin Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Dactinomycin DC2P1A6 Dactinomycin Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + DFN-15 DCE5BOA DFN-15 Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + PMID28460551-Compound-2 DCW2YZA PMID28460551-Compound-2 Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Crizotinib DCA8MEO Crizotinib Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Crizotinib DCP5II9 Crizotinib Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Crizotinib DC0LRHZ Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Crizotinib DCSPP88 Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Cyclophosphamide DCOP0YV Cyclophosphamide Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + LIAROZOLE DCYM99B LIAROZOLE Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + LIAROZOLE DC349BI LIAROZOLE Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Vismodegib DCX77R9 Vismodegib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Vismodegib DCSXFJL Vismodegib Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Vismodegib DCDEYXT Vismodegib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Vismodegib DC8T25I Vismodegib Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Vismodegib DC66U4C Vismodegib Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Isoniazid DCORH5O Isoniazid Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Isoniazid DCP0AXY Isoniazid Glioblastoma (Cell Line: SNB-75) [2]
ABIRATERONE + Isoniazid DC477Q5 Isoniazid Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Arsenic trioxide DCBSAM3 Arsenic trioxide Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Vemurafenib DC9DLT6 Vemurafenib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Vemurafenib DCCCAT7 Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Lenalidomide DCS0YIN Lenalidomide Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Plicamycin DCM3SEG Plicamycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Plicamycin DCLRX99 Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Plicamycin DCSSNM4 Plicamycin Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Plicamycin DCW9DMG Plicamycin Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Plicamycin DCG14QT Plicamycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
ABIRATERONE + Plicamycin DCY8SRU Plicamycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Plicamycin DCHM91D Plicamycin Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Plicamycin DCM9G39 Plicamycin Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Plicamycin DCX3VDW Plicamycin Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Plicamycin DC15MP5 Plicamycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Plicamycin DCK9BT7 Plicamycin Glioblastoma (Cell Line: SNB-75) [2]
ABIRATERONE + Plicamycin DCWHA60 Plicamycin Glioma (Cell Line: SF-295) [2]
ABIRATERONE + Plicamycin DCUFL1V Plicamycin Glioma (Cell Line: SF-539) [2]
ABIRATERONE + Plicamycin DCC78EE Plicamycin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Plicamycin DCEWB22 Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Plicamycin DC4YK5L Plicamycin Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Plicamycin DCUYOOI Plicamycin Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Nilotinib DCD99J7 Nilotinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
ABIRATERONE + Nilotinib DCI1LKN Nilotinib Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Nilotinib DC80G3J Nilotinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Nilotinib DCFF4RO Nilotinib Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Nilotinib DCB2Q1K Nilotinib Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Thioguanine DCWDU0S Thioguanine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Thioguanine DC54JZK Thioguanine Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Thioguanine DC83IWQ Thioguanine Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Thioguanine DCS4UNB Thioguanine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Thioguanine DC5EU1O Thioguanine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Thioguanine DCK2M67 Thioguanine Glioblastoma (Cell Line: SNB-75) [2]
ABIRATERONE + Thioguanine DCAA72Z Thioguanine Glioma (Cell Line: SF-295) [2]
ABIRATERONE + Thioguanine DCF2ABE Thioguanine Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + 10-hydroxycamptothecin DC148N2 10-hydroxycamptothecin Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + 10-hydroxycamptothecin DCYUAME 10-hydroxycamptothecin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Amonafide DCTIBIN Amonafide Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Amonafide DCVF2O6 Amonafide Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Pralatrexate DCUXLGJ Pralatrexate Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
ABIRATERONE + Pralatrexate DCXRKKP Pralatrexate Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Terameprocol DC5446Y Terameprocol Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Terameprocol DCDOT6F Terameprocol Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Terameprocol DC0XUK7 Terameprocol Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + SCH 727965 DC03JEG SCH 727965 Glioblastoma (Cell Line: SNB-75) [2]
ABIRATERONE + SCH 727965 DCYANWA SCH 727965 Glioma (Cell Line: SF-268) [2]
ABIRATERONE + SCH 727965 DCHTACI SCH 727965 Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Ifosfamide DCGKXKA Ifosfamide Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Ifosfamide DC8S5OC Ifosfamide Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Ifosfamide DC73ZZI Ifosfamide Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Dexrazoxane DCMP8YH Dexrazoxane Glioma (Cell Line: SF-539) [2]
ABIRATERONE + Docetaxel DCC7WBE Docetaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Docetaxel DCW9IYN Docetaxel Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Docetaxel DCV7FWX Docetaxel Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Docetaxel DCGBDDG Docetaxel Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Docetaxel DC1BVQS Docetaxel Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Docetaxel DCKSE8K Docetaxel Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Docetaxel DC3LDCZ Docetaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Docetaxel DC80HQ5 Docetaxel Glioma (Cell Line: SF-539) [2]
ABIRATERONE + Docetaxel DCPTGNZ Docetaxel Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Raloxifene DCSACHY Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Raloxifene DCTM6FL Raloxifene Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Raloxifene DCXQMD7 Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
ABIRATERONE + Raloxifene DCQ14AB Raloxifene Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Raloxifene DCMR12C Raloxifene Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Raloxifene DCV3SQE Raloxifene Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Raloxifene DCKNT1B Raloxifene Glioblastoma (Cell Line: SNB-75) [2]
ABIRATERONE + Raloxifene DCR5M3A Raloxifene Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Bendamustine hydrochloride DCHCLB1 Bendamustine hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Bendamustine hydrochloride DCXSJSM Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Bendamustine hydrochloride DCSHW7D Bendamustine hydrochloride Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Bendamustine hydrochloride DCCXZ32 Bendamustine hydrochloride Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Bendamustine hydrochloride DCMJWP0 Bendamustine hydrochloride Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Trifluridine DCVMKL1 Trifluridine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Trifluridine DC780IS Trifluridine Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Trifluridine DCNV2GV Trifluridine Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Trifluridine DCGD64K Trifluridine Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Trifluridine DCISU6Y Trifluridine Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Sirolimus DCRHQMW Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Sirolimus DCT44AK Sirolimus Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Sirolimus DCLX2FC Sirolimus Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Sirolimus DCXJN9I Sirolimus Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Sirolimus DCHQEWA Sirolimus Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
ABIRATERONE + Sirolimus DCI1M34 Sirolimus Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Sirolimus DCHII5R Sirolimus Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Sirolimus DC9MMQT Sirolimus Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Sirolimus DCSXYW4 Sirolimus Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Letrozole DCFI89C Letrozole Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Letrozole DC6A079 Letrozole Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Letrozole DC1RVPR Letrozole Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Mitomycin DCN7QZN Mitomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Mitomycin DC801YA Mitomycin Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Mitomycin DCW9X7V Mitomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Mitomycin DCD8GFO Mitomycin Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Mitomycin DCVH9MZ Mitomycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Mitomycin DC3L1PF Mitomycin Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + SY-1425 DC2HLXJ SY-1425 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + SY-1425 DCN52PI SY-1425 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
ABIRATERONE + SY-1425 DC26CJX SY-1425 Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + SY-1425 DCUW77F SY-1425 Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + SY-1425 DC1XX9N SY-1425 Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Uracil mustard DCA9LYN Uracil mustard Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Uracil mustard DCYTEU1 Uracil mustard Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Uracil mustard DCV7CVY Uracil mustard Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Uracil mustard DC1BUQT Uracil mustard Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Uracil mustard DC9I1OL Uracil mustard Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Uracil mustard DCNK2AY Uracil mustard Glioma (Cell Line: SF-295) [2]
ABIRATERONE + Uracil mustard DC60KCI Uracil mustard Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Uracil mustard DCSMOYD Uracil mustard Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Vincristine DC9HHV9 Vincristine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Vincristine DC95AF7 Vincristine Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Vincristine DCN8WVN Vincristine Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Vincristine DCCR03I Vincristine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Vincristine DCGKC3Z Vincristine Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Vincristine DCV4KGM Vincristine Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Vincristine DCYJ5J5 Vincristine Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Arfolitixorin DC1S32L Arfolitixorin Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + BIO-300 DCJ378D BIO-300 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + BIO-300 DCY4M3E BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + BIO-300 DCY6Z1X BIO-300 Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + BIO-300 DCDBPMK BIO-300 Glioma (Cell Line: SF-539) [2]
ABIRATERONE + BIO-300 DC4LKRS BIO-300 Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + BIO-300 DCXAJAQ BIO-300 Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Altretamine DC6GVW2 Altretamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Altretamine DCIO3D7 Altretamine Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Altretamine DCA0EJG Altretamine Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + TEM DCG0EOS TEM Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + TEM DC8HROL TEM Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + TEM DC7UZ0R TEM Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + JNK-IN-8 DCI8DK2 JNK-IN-8 Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Indazole derivative 5 DC9XTHR Indazole derivative 5 Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Indazole derivative 5 DCDKTRM Indazole derivative 5 Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Indazole derivative 5 DCVHE9C Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Indazole derivative 5 DCND3JP Indazole derivative 5 Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Imatinib DCCC1YP Imatinib Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Imatinib DCV4TFS Imatinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Imatinib DC6O0ZI Imatinib Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Bleomycin DCK4ONP Bleomycin Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Bleomycin DC3DGW8 Bleomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Bleomycin DCJKQE3 Bleomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Bleomycin DCIUTHU Bleomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Bleomycin DCP981X Bleomycin Glioblastoma (Cell Line: SNB-75) [2]
ABIRATERONE + Bleomycin DCCPTW3 Bleomycin Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Bortezomib DCGFSHC Bortezomib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Bortezomib DCEK6SH Bortezomib Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Bortezomib DC4DUS7 Bortezomib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
ABIRATERONE + Bortezomib DCTOLGT Bortezomib Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Anastrozole DCH2W42 Anastrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Anastrozole DC19U2O Anastrozole Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Anastrozole DCMYPEA Anastrozole Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Dacarbazine DCCYU60 Dacarbazine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Dacarbazine DCLIKY7 Dacarbazine Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Dacarbazine DCM24A9 Dacarbazine Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Dacarbazine DCN7VVP Dacarbazine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Dacarbazine DCE2TI4 Dacarbazine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Dacarbazine DCHRAZM Dacarbazine Glioma (Cell Line: SF-295) [2]
ABIRATERONE + Dacarbazine DCCARHZ Dacarbazine Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Dacarbazine DCMAUHB Dacarbazine Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Valrubicin DCUPUSV Valrubicin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Valrubicin DCYC2Y8 Valrubicin Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Valrubicin DCIGDOY Valrubicin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Valrubicin DCDC5K0 Valrubicin Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Topotecan DC0U7DK Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Topotecan DCLRNO8 Topotecan Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Topotecan DC04AQH Topotecan Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Topotecan DC7JS8J Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Cabazitaxel DCJ0WAD Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Cabazitaxel DCP4TN0 Cabazitaxel Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Cabazitaxel DC159T4 Cabazitaxel Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Cabazitaxel DCJJ1OH Cabazitaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
ABIRATERONE + Cabazitaxel DC2WGZL Cabazitaxel Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Cabazitaxel DCNUQHC Cabazitaxel Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Cabazitaxel DCY8ZRB Cabazitaxel Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Cabazitaxel DCZ8LDN Cabazitaxel Glioma (Cell Line: SF-539) [2]
ABIRATERONE + Cabazitaxel DC0RMWZ Cabazitaxel Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Epirubicin DCOZMKA Epirubicin Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Epirubicin DCLYZ88 Epirubicin Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Epirubicin DCHAZZT Epirubicin Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Epirubicin DCO0OVH Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Epirubicin DCSQ42T Epirubicin Glioma (Cell Line: SF-539) [2]
ABIRATERONE + Epirubicin DC35RMN Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Epirubicin DC8WV02 Epirubicin Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Cisplatin DCHBVZQ Cisplatin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Cisplatin DC7KNOM Cisplatin Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Cisplatin DCJBSJW Cisplatin Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Cisplatin DCNMKCN Cisplatin Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Vandetanib DC0K9QA Vandetanib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Vandetanib DCS8EE7 Vandetanib Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Vandetanib DC44GG2 Vandetanib Glioma (Cell Line: SF-295) [2]
ABIRATERONE + Vandetanib DCBTQCE Vandetanib Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Vandetanib DCQEXED Vandetanib Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Sorafenib DCKOTAE Sorafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Sorafenib DCA4OS0 Sorafenib Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + ER819762 DC8YYWX ER819762 Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Azacitidine DCP72Y1 Azacitidine Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Azacitidine DCNFJ7G Azacitidine Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Azacitidine DCI1Z40 Azacitidine Glioblastoma (Cell Line: SNB-75) [2]
ABIRATERONE + Pomalidomide DCVK77Q Pomalidomide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Pomalidomide DC5B0TS Pomalidomide Clear cell renal cell carcinoma (Cell Line: A498) [2]
ABIRATERONE + Pomalidomide DC27L74 Pomalidomide Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Pomalidomide DC7XPEK Pomalidomide Glioblastoma (Cell Line: SNB-75) [2]
ABIRATERONE + Pomalidomide DCYWOTM Pomalidomide Papillary renal cell carcinoma (Cell Line: ACHN) [2]
ABIRATERONE + Pomalidomide DCMNEQS Pomalidomide Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Vinflunine DC7X3W0 Vinflunine Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Vinflunine DCT9L6D Vinflunine Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Vinflunine DC8N3X4 Vinflunine Glioma (Cell Line: SF-539) [2]
ABIRATERONE + Vinflunine DC2J084 Vinflunine Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Vinflunine DC3KPRQ Vinflunine Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Vinflunine DCY37RG Vinflunine Renal cell carcinoma (Cell Line: SN12C) [2]
ABIRATERONE + Mercaptopurine DCBTLGS Mercaptopurine Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Mepacrine DCA8IQM Mepacrine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Mepacrine DCFRQJ9 Mepacrine Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Taxol DCAQ75W Taxol Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Taxol DC8SVDT Taxol Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Taxol DCCC1G3 Taxol Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Taxol DCM6LCX Taxol Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
ABIRATERONE + Taxol DCKDSR0 Taxol Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Taxol DC0P0EW Taxol Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Taxol DCUH30M Taxol Glioma (Cell Line: SF-295) [2]
ABIRATERONE + Taxol DCMIERP Taxol Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Taxol DCMMSI0 Taxol Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Fludarabine DCESWHV Fludarabine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Fludarabine DCH0KFM Fludarabine Plasma cell myeloma (Cell Line: RPMI-8226) [2]
ABIRATERONE + Fludarabine DCIKH3Q Fludarabine Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + PMID28870136-Compound-43 DCJLIM7 PMID28870136-Compound-43 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + FORMESTANE DCP1NA6 FORMESTANE Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + FORMESTANE DCQKMC8 FORMESTANE Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Aminolevulinic Acid Hydrochloride DC0BUPZ Aminolevulinic Acid Hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
ABIRATERONE + Aminolevulinic Acid Hydrochloride DCP5BYH Aminolevulinic Acid Hydrochloride Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Estramustine DCKIFIE Estramustine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Estramustine DCRIEW8 Estramustine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Estramustine DCJJWHU Estramustine Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Digitoxin DCFRJ3A Digitoxin Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Digitoxin DCP1WD6 Digitoxin Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Digitoxin DCRG75V Digitoxin Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Busulfan DCADIFJ Busulfan Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Dasatinib DC2ELHG Dasatinib Astrocytoma (Cell Line: U251) [2]
ABIRATERONE + Dasatinib DCDE0R2 Dasatinib Chronic myelogenous leukemia (Cell Line: K-562) [2]
ABIRATERONE + Dasatinib DCN3LUV Dasatinib Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
ABIRATERONE + Dasatinib DCS68C2 Dasatinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
ABIRATERONE + Dasatinib DC640KB Dasatinib Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Pentostatin DCO9V7V Pentostatin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Pentostatin DCFVFCC Pentostatin Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Fulvestrant DC5QPFY Fulvestrant Invasive ductal carcinoma (Cell Line: T-47D) [3]
ABIRATERONE + Fulvestrant DCM8VZG Fulvestrant Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Gefitinib DCOS80J Gefitinib Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Gefitinib DCEVHT9 Gefitinib Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Gefitinib DCOJGIK Gefitinib Invasive ductal carcinoma (Cell Line: T-47D) [3]
ABIRATERONE + Ruxolitinib DCAST26 Ruxolitinib Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Ixabepilone DCXXM9C Ixabepilone Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Ixabepilone DCQ96LH Ixabepilone Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Ixabepilone DC4WZA1 Ixabepilone Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Ixabepilone DC9FWLL Ixabepilone Invasive ductal carcinoma (Cell Line: T-47D) [3]
ABIRATERONE + Dactinomycin DCBYB1Y Dactinomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Dactinomycin DCTMPDZ Dactinomycin Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + Dactinomycin DCA5BU2 Dactinomycin Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Dactinomycin DCRHEV1 Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Dactinomycin DCGFO32 Dactinomycin Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Dactinomycin DCTKWRN Dactinomycin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
ABIRATERONE + Dactinomycin DCUR1QK Dactinomycin Invasive ductal carcinoma (Cell Line: T-47D) [3]
ABIRATERONE + DFN-15 DC3FKF9 DFN-15 Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + DFN-15 DCKRLRB DFN-15 Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Lapatinib DCCW3EN Lapatinib Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + PMID28460551-Compound-2 DCGA9HM PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + Crizotinib DCM74TX Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Crizotinib DCKWJHP Crizotinib Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Crizotinib DCY0J6K Crizotinib Invasive ductal carcinoma (Cell Line: HS 578T) [3]
ABIRATERONE + Vismodegib DCZ1A85 Vismodegib Invasive ductal carcinoma (Cell Line: T-47D) [3]
ABIRATERONE + Isoniazid DCRPQ0A Isoniazid Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Plicamycin DC3A52F Plicamycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Plicamycin DCC0NXQ Plicamycin Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Plicamycin DC20TBS Plicamycin Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Plicamycin DCJIWN6 Plicamycin Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Plicamycin DCBCYQ1 Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Plicamycin DCKC3D6 Plicamycin Invasive ductal carcinoma (Cell Line: T-47D) [3]
ABIRATERONE + Plicamycin DCK3LOJ Plicamycin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
ABIRATERONE + Nilotinib DC43POE Nilotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Thioguanine DCUQZDL Thioguanine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Thioguanine DC6EH7G Thioguanine Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + 10-hydroxycamptothecin DCTCAUC 10-hydroxycamptothecin Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + Amonafide DC53XKB Amonafide Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Terameprocol DCNHKCN Terameprocol Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + SCH 727965 DC8PN0O SCH 727965 Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + SCH 727965 DC9WBZZ SCH 727965 Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Ifosfamide DCQEYRR Ifosfamide Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Ifosfamide DCP7F16 Ifosfamide Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Docetaxel DCKQI2A Docetaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Docetaxel DCMCZAW Docetaxel Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + Docetaxel DCNH026 Docetaxel Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Docetaxel DC22X7O Docetaxel Invasive ductal carcinoma (Cell Line: T-47D) [3]
ABIRATERONE + Raloxifene DCELGUC Raloxifene Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Raloxifene DC8S136 Raloxifene Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Raloxifene DCK4XNC Raloxifene Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Raloxifene DC03WRB Raloxifene Invasive ductal carcinoma (Cell Line: T-47D) [3]
ABIRATERONE + Raloxifene DCP5HZ3 Raloxifene Invasive ductal carcinoma (Cell Line: HS 578T) [3]
ABIRATERONE + Bendamustine hydrochloride DCO0EXY Bendamustine hydrochloride Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Bendamustine hydrochloride DC6LR8H Bendamustine hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Trifluridine DC15MK8 Trifluridine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Trifluridine DC1BWT9 Trifluridine Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Sirolimus DC2C5DK Sirolimus Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Sirolimus DCF33KO Sirolimus Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Sirolimus DC28YHQ Sirolimus Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Sirolimus DCJOVC6 Sirolimus Invasive ductal carcinoma (Cell Line: HS 578T) [3]
ABIRATERONE + Letrozole DCAU6LG Letrozole Invasive ductal carcinoma (Cell Line: HS 578T) [3]
ABIRATERONE + Letrozole DC1JVNU Letrozole Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Mitomycin DCTVHMW Mitomycin Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + Mitomycin DCFUHPD Mitomycin Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Mitomycin DCGTECQ Mitomycin Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + SY-1425 DCWAY8F SY-1425 Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Uracil mustard DC3EVNE Uracil mustard Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Uracil mustard DCAPZRN Uracil mustard Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Uracil mustard DCF3SXR Uracil mustard Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Vincristine DCL1IZW Vincristine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Vincristine DCFOMSM Vincristine Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Arfolitixorin DCCKRNS Arfolitixorin Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + BIO-300 DCGMH4G BIO-300 Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + BIO-300 DCVER8D BIO-300 Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + BIO-300 DCZ7F0H BIO-300 Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + BIO-300 DCW9574 BIO-300 Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Altretamine DCUHHVN Altretamine Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Altretamine DC1BJ6Q Altretamine Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + TEM DC5GL54 TEM Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + TEM DC7OVII TEM Invasive ductal carcinoma (Cell Line: T-47D) [3]
ABIRATERONE + TEM DCFA13W TEM Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + JNK-IN-8 DCQVIOE JNK-IN-8 Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Idarubicin DCIB03Q Idarubicin Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Indazole derivative 5 DC98QNJ Indazole derivative 5 Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Indazole derivative 5 DC2D5HA Indazole derivative 5 Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Indazole derivative 5 DCDHIOL Indazole derivative 5 Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Indazole derivative 5 DCLYH34 Indazole derivative 5 Invasive ductal carcinoma (Cell Line: T-47D) [3]
ABIRATERONE + Imatinib DC0UBUH Imatinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Bleomycin DCFM2ML Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Bleomycin DC6VV7D Bleomycin Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Bleomycin DCC1I2V Bleomycin Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Valrubicin DCUDYJ7 Valrubicin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Valrubicin DC3NJB8 Valrubicin Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Valrubicin DCSDPPQ Valrubicin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
ABIRATERONE + Valrubicin DCFECD2 Valrubicin Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Topotecan DCLINMV Topotecan Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Topotecan DCW9G53 Topotecan Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Cabazitaxel DCFKCXX Cabazitaxel Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Epirubicin DCMUSL3 Epirubicin Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Epirubicin DC7YNTK Epirubicin Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Cisplatin DCVSL1A Cisplatin Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Vandetanib DCK32G8 Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [3]
ABIRATERONE + Chlorambucil DCRSTKA Chlorambucil Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Sorafenib DCHB4V2 Sorafenib Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Azacitidine DCHLSLV Azacitidine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Vinflunine DCLS1BG Vinflunine Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Vinflunine DCYC3JI Vinflunine Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + Taxol DCI97DE Taxol Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Taxol DCE9HYZ Taxol Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + Taxol DCSCRU4 Taxol Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Taxol DCADALD Taxol Colon carcinoma (Cell Line: KM12) [3]
ABIRATERONE + FORMESTANE DCVFY1B FORMESTANE Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Estramustine DCVL7Z6 Estramustine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Estramustine DCF770Q Estramustine Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + Estramustine DCSHYT9 Estramustine Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Digitoxin DC9Z7UN Digitoxin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Digitoxin DCQBY84 Digitoxin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
ABIRATERONE + Dasatinib DCLOC90 Dasatinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Dasatinib DCHJTLS Dasatinib Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + Mechlorethamine DC809J1 Mechlorethamine Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Mechlorethamine DC8LYYX Mechlorethamine Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Pentostatin DCLNQLX Pentostatin Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Pentostatin DCC5YWI Pentostatin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
ABIRATERONE + Pentostatin DC9RPSD Pentostatin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Pentostatin DCKY0FX Pentostatin Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Picoplatin DC2OKH4 Picoplatin Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Picoplatin DC1KMSQ Picoplatin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Fulvestrant DCBAHUO Fulvestrant Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Fulvestrant DCTQWP7 Fulvestrant Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Fulvestrant DCF3SE9 Fulvestrant High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
ABIRATERONE + Fulvestrant DCX87AT Fulvestrant Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Fulvestrant DCEX7ZN Fulvestrant Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + Fulvestrant DC6AW0W Fulvestrant Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Fulvestrant DCWPFWD Fulvestrant Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Fulvestrant DCNA1TR Fulvestrant Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Gefitinib DCJEVY6 Gefitinib Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Gefitinib DCIQHVB Gefitinib Adenocarcinoma (Cell Line: A549) [4]
ABIRATERONE + Gefitinib DCGZP1S Gefitinib Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Gefitinib DC1SK0I Gefitinib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Gefitinib DCLGJXX Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Gefitinib DCFN0UD Gefitinib Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Gefitinib DC6R5F8 Gefitinib Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Gefitinib DC8U9XG Gefitinib Malignant melanoma (Cell Line: UACC62) [4]
ABIRATERONE + Gefitinib DCHX3QO Gefitinib Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Gefitinib DCV6PPN Gefitinib Melanoma (Cell Line: UACC-257) [4]
ABIRATERONE + Gefitinib DCIM11F Gefitinib Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + Gefitinib DC98OUG Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Gefitinib DCOAP76 Gefitinib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
ABIRATERONE + Gefitinib DCJM37R Gefitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Gefitinib DCKUPQO Gefitinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + Ruxolitinib DCCLGM8 Ruxolitinib Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Ruxolitinib DCU94JH Ruxolitinib Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Ruxolitinib DCSFQ09 Ruxolitinib Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Ruxolitinib DCOSCRC Ruxolitinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Hepzato DC2D550 Hepzato High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Hepzato DCKZJI3 Hepzato Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Hepzato DCOHUTU Hepzato Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Hepzato DC8Z9BE Hepzato Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Ixabepilone DC43MZS Ixabepilone Adenocarcinoma (Cell Line: HCC-2998) [4]
ABIRATERONE + Ixabepilone DCOKC2R Ixabepilone Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Ixabepilone DCFMMAO Ixabepilone Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Ixabepilone DCM5ZTM Ixabepilone Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Ixabepilone DC4MYSJ Ixabepilone Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Dactinomycin DCUKD9J Dactinomycin Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Dactinomycin DCGJI4O Dactinomycin Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Dactinomycin DC0LGI2 Dactinomycin Adenocarcinoma (Cell Line: NCIH23) [4]
ABIRATERONE + Dactinomycin DCT78BH Dactinomycin Adenocarcinoma (Cell Line: A549) [4]
ABIRATERONE + Dactinomycin DCPV0S7 Dactinomycin Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + Dactinomycin DCL3A4R Dactinomycin Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Dactinomycin DCNIHG5 Dactinomycin Adenocarcinoma (Cell Line: HCC-2998) [4]
ABIRATERONE + Dactinomycin DCYHVKQ Dactinomycin Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Dactinomycin DCZ4D73 Dactinomycin Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + Dactinomycin DC6BOGP Dactinomycin Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Dactinomycin DC7O488 Dactinomycin Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Dactinomycin DC5315A Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
ABIRATERONE + Dactinomycin DC0IG5C Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Dactinomycin DCSJKVV Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Dactinomycin DCF9FPD Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Dactinomycin DCI9RNU Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
ABIRATERONE + Dactinomycin DC2I5KN Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Dactinomycin DC6L32F Dactinomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Dactinomycin DCQ9YQO Dactinomycin Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Dactinomycin DCMCVER Dactinomycin Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Dactinomycin DCR653U Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Dactinomycin DCU6QJL Dactinomycin Malignant melanoma (Cell Line: UACC62) [4]
ABIRATERONE + Dactinomycin DC8GMKH Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Dactinomycin DC03GH5 Dactinomycin Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Dactinomycin DCUPW4R Dactinomycin Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + Dactinomycin DCPUBNP Dactinomycin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Dactinomycin DCLC22H Dactinomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Dactinomycin DCVL6C9 Dactinomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
ABIRATERONE + Dactinomycin DCFDP4F Dactinomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Dactinomycin DCNVGJY Dactinomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + Dactinomycin DC34BZI Dactinomycin Prostate carcinoma (Cell Line: PC-3) [4]
ABIRATERONE + DFN-15 DCBTQ1M DFN-15 Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
ABIRATERONE + DFN-15 DCDJILT DFN-15 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
ABIRATERONE + DFN-15 DC8D2B2 DFN-15 Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + DFN-15 DCD9UX8 DFN-15 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Lapatinib DCD936W Lapatinib Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Lapatinib DCW2DD3 Lapatinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + PMID28460551-Compound-2 DCQ3A37 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + PMID28460551-Compound-2 DCM0ZNH PMID28460551-Compound-2 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + PMID28460551-Compound-2 DCVNKHB PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + PMID28460551-Compound-2 DCUTYUL PMID28460551-Compound-2 Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + PMID28460551-Compound-2 DCCXXWW PMID28460551-Compound-2 Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + PMID28460551-Compound-2 DCUDBXQ PMID28460551-Compound-2 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Crizotinib DCNVG75 Crizotinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Crizotinib DC67F7D Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Crizotinib DC7TM8Q Crizotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Cyclophosphamide DC9WC0B Cyclophosphamide Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + LIAROZOLE DC99LKP LIAROZOLE Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + LIAROZOLE DCIIVLD LIAROZOLE Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + Vismodegib DC52YOY Vismodegib Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Vismodegib DC23PNW Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Isoniazid DC2XM01 Isoniazid Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Isoniazid DCU9CBT Isoniazid Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Isoniazid DC57W56 Isoniazid Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
ABIRATERONE + Isoniazid DC8D55B Isoniazid Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Arsenic trioxide DCEW4WX Arsenic trioxide Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Vemurafenib DCOE67G Vemurafenib Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Vemurafenib DCJ31D6 Vemurafenib Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Vemurafenib DCZNZ5H Vemurafenib Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + Vemurafenib DCK5BVU Vemurafenib Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Vemurafenib DCBK5JJ Vemurafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Plicamycin DCP4C65 Plicamycin Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Plicamycin DC08NY5 Plicamycin Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Plicamycin DCDKMVK Plicamycin Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + Plicamycin DCKR6JF Plicamycin Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Plicamycin DCI5JL6 Plicamycin Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Plicamycin DCXSE44 Plicamycin Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Plicamycin DC8I3XG Plicamycin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
ABIRATERONE + Plicamycin DCJ2GEH Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Plicamycin DC0TMU8 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
ABIRATERONE + Plicamycin DCNIN8Z Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Plicamycin DC4ID0K Plicamycin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Plicamycin DCYA9D8 Plicamycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Plicamycin DC2QCZE Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Plicamycin DCO7KCZ Plicamycin Malignant melanoma (Cell Line: UACC62) [4]
ABIRATERONE + Plicamycin DCXANDV Plicamycin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Plicamycin DCO8MWI Plicamycin Melanoma (Cell Line: UACC-257) [4]
ABIRATERONE + Plicamycin DCTAERX Plicamycin Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Plicamycin DC2TZ3Q Plicamycin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Plicamycin DCOORA0 Plicamycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Plicamycin DC088NU Plicamycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Nilotinib DCXQPZ3 Nilotinib Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Nilotinib DC75MJE Nilotinib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Nilotinib DCCFR4Y Nilotinib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Nilotinib DCZB1KN Nilotinib Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Nilotinib DCYOKLV Nilotinib Prostate carcinoma (Cell Line: PC-3) [4]
ABIRATERONE + Thioguanine DC3ST12 Thioguanine Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Thioguanine DCXRKQV Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Thioguanine DCONRXO Thioguanine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Thioguanine DCCECF8 Thioguanine Prostate carcinoma (Cell Line: PC-3) [4]
ABIRATERONE + Triapine DCJHL9G Triapine Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
ABIRATERONE + Triapine DCUY7P4 Triapine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Triapine DCEFH4Z Triapine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Triapine DCWNJP7 Triapine Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + 10-hydroxycamptothecin DCEAU26 10-hydroxycamptothecin Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + 10-hydroxycamptothecin DCDE2A9 10-hydroxycamptothecin Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + 10-hydroxycamptothecin DCLHYDX 10-hydroxycamptothecin Adenocarcinoma (Cell Line: HCC-2998) [4]
ABIRATERONE + 10-hydroxycamptothecin DCG530I 10-hydroxycamptothecin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + 10-hydroxycamptothecin DCZ6N6G 10-hydroxycamptothecin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + 10-hydroxycamptothecin DCHELE6 10-hydroxycamptothecin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + 10-hydroxycamptothecin DCD2EUY 10-hydroxycamptothecin Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + 10-hydroxycamptothecin DCO5DU4 10-hydroxycamptothecin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Topetecan DCQEMCP Topetecan Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Topetecan DC3IP0D Topetecan Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Amonafide DCYN3JC Amonafide Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Pralatrexate DCEOZP5 Pralatrexate Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Pralatrexate DCWEQH5 Pralatrexate Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Terameprocol DC8Z38C Terameprocol Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Terameprocol DCSSIRZ Terameprocol Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + Terameprocol DCZQLF8 Terameprocol High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Terameprocol DCNYSY3 Terameprocol Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Terameprocol DC5I5LR Terameprocol Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Terameprocol DC5UWPI Terameprocol Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Terameprocol DC2VEVL Terameprocol Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
ABIRATERONE + Terameprocol DCTXO9W Terameprocol Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + SCH 727965 DCZA38C SCH 727965 Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + SCH 727965 DCIILG5 SCH 727965 Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + SCH 727965 DCJH1OP SCH 727965 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Ifosfamide DCZCQYT Ifosfamide Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Dexrazoxane DCH645M Dexrazoxane Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Dexrazoxane DCK7QO9 Dexrazoxane Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Docetaxel DC3RUFP Docetaxel Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Docetaxel DCKAXAL Docetaxel Adenocarcinoma (Cell Line: NCIH23) [4]
ABIRATERONE + Docetaxel DC3VEMX Docetaxel Adenocarcinoma (Cell Line: A549) [4]
ABIRATERONE + Docetaxel DCPXSN8 Docetaxel Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + Docetaxel DCFUFSX Docetaxel Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Docetaxel DCW6KLK Docetaxel Adenocarcinoma (Cell Line: HCC-2998) [4]
ABIRATERONE + Docetaxel DCH06JM Docetaxel Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Docetaxel DCWZBYF Docetaxel Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Docetaxel DCUGHZN Docetaxel Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Docetaxel DC3XDCQ Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Docetaxel DCI4FQO Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
ABIRATERONE + Docetaxel DCS8KXH Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Docetaxel DC2831Z Docetaxel Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Docetaxel DCW5S8S Docetaxel Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Docetaxel DCI6EOA Docetaxel Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Docetaxel DCI1A9J Docetaxel Melanoma (Cell Line: UACC-257) [4]
ABIRATERONE + Raloxifene DCLHYLO Raloxifene Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Raloxifene DCJC9CL Raloxifene Adenocarcinoma (Cell Line: NCIH23) [4]
ABIRATERONE + Raloxifene DCCLFLB Raloxifene Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Raloxifene DC8A96I Raloxifene Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + Raloxifene DC58G3J Raloxifene Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Raloxifene DCNG3B5 Raloxifene Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Raloxifene DCKWIP2 Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Raloxifene DCAPMSM Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Raloxifene DCLXAAQ Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Raloxifene DC7OCPC Raloxifene Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Raloxifene DCML8JI Raloxifene Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Raloxifene DCXDUSI Raloxifene Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Raloxifene DCNCBQ9 Raloxifene Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Raloxifene DCMN4MU Raloxifene Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Raloxifene DCYL1PB Raloxifene Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + Raloxifene DCY2CUS Raloxifene Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Raloxifene DC8IZGS Raloxifene Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
ABIRATERONE + Raloxifene DCBT4M9 Raloxifene Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Raloxifene DCFY0Q5 Raloxifene Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + Bendamustine hydrochloride DCKRQU7 Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [4]
ABIRATERONE + Bendamustine hydrochloride DCDIWR7 Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + Bendamustine hydrochloride DCGV9FW Bendamustine hydrochloride Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + Bendamustine hydrochloride DCKV1IP Bendamustine hydrochloride Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Bendamustine hydrochloride DCCJYNP Bendamustine hydrochloride Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Bendamustine hydrochloride DCKY211 Bendamustine hydrochloride High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Bendamustine hydrochloride DC11VK3 Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Bendamustine hydrochloride DCBJCN0 Bendamustine hydrochloride Malignant melanoma (Cell Line: UACC62) [4]
ABIRATERONE + Bendamustine hydrochloride DC9MRLN Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + Bendamustine hydrochloride DCOIL69 Bendamustine hydrochloride Melanoma (Cell Line: UACC-257) [4]
ABIRATERONE + Bendamustine hydrochloride DC4RKBX Bendamustine hydrochloride Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Bendamustine hydrochloride DC2YDX0 Bendamustine hydrochloride Prostate carcinoma (Cell Line: PC-3) [4]
ABIRATERONE + Trifluridine DC3H05B Trifluridine Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + Trifluridine DCJSJW1 Trifluridine Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Trifluridine DCADM2T Trifluridine Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Trifluridine DCQVJIF Trifluridine Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Sirolimus DCFXF77 Sirolimus Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Sirolimus DCB8PHP Sirolimus Adenocarcinoma (Cell Line: A549) [4]
ABIRATERONE + Sirolimus DCGEUGE Sirolimus Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Sirolimus DCWXSQC Sirolimus Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + Sirolimus DCQKCAW Sirolimus Adenocarcinoma (Cell Line: HCC-2998) [4]
ABIRATERONE + Sirolimus DC0J3S4 Sirolimus Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Sirolimus DCCGGT0 Sirolimus Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + Sirolimus DC1LCIN Sirolimus Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Sirolimus DCZB25I Sirolimus Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Sirolimus DC0GRMS Sirolimus Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Sirolimus DCX7QV2 Sirolimus Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Sirolimus DC3E7MM Sirolimus Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Sirolimus DC44BU7 Sirolimus Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Sirolimus DCDUCJA Sirolimus Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Sirolimus DC2E5H6 Sirolimus Malignant melanoma (Cell Line: UACC62) [4]
ABIRATERONE + Sirolimus DCEH1XV Sirolimus Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + Letrozole DCNR2OI Letrozole Adenocarcinoma (Cell Line: NCIH23) [4]
ABIRATERONE + Letrozole DC4ONZ7 Letrozole Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Letrozole DCIB9WA Letrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Letrozole DC34FMB Letrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Mitomycin DCYIHNX Mitomycin Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Mitomycin DCLZPEI Mitomycin Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Mitomycin DC7DBKG Mitomycin Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + Mitomycin DCODB33 Mitomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Mitomycin DCOO3BK Mitomycin Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Mitomycin DCL4JVN Mitomycin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Mitomycin DC6CX8Y Mitomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + SY-1425 DC1M1C9 SY-1425 Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + SY-1425 DC6S94P SY-1425 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + SY-1425 DCAEKCR SY-1425 Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + SY-1425 DC73WH3 SY-1425 Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + SY-1425 DCSCE32 SY-1425 Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + SY-1425 DC8K94B SY-1425 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Uracil mustard DCRFAJW Uracil mustard Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Uracil mustard DCPOZAB Uracil mustard Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + Uracil mustard DC3IMSZ Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Uracil mustard DCI0YQB Uracil mustard Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Uracil mustard DCJ34B6 Uracil mustard Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Uracil mustard DCHRFDT Uracil mustard Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Vincristine DCF5WWX Vincristine Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Vincristine DC2IF08 Vincristine Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Vincristine DC5KYNC Vincristine Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Vincristine DC90QTP Vincristine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Vincristine DCQMPZK Vincristine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Vincristine DC0NX5E Vincristine Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Vincristine DCNZ7PF Vincristine Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Arfolitixorin DCYA4W8 Arfolitixorin Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Arfolitixorin DCI8K6N Arfolitixorin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + BIO-300 DCOJUXG BIO-300 Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + BIO-300 DCUQOL1 BIO-300 Adenocarcinoma (Cell Line: NCIH23) [4]
ABIRATERONE + BIO-300 DCEUISK BIO-300 Adenocarcinoma (Cell Line: A549) [4]
ABIRATERONE + BIO-300 DC4ROT5 BIO-300 Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + BIO-300 DCH4V7Z BIO-300 Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + BIO-300 DCX2JO5 BIO-300 Adenocarcinoma (Cell Line: HCC-2998) [4]
ABIRATERONE + BIO-300 DCDLZLP BIO-300 Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + BIO-300 DCPKYQB BIO-300 Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + BIO-300 DCBGA2Q BIO-300 Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + BIO-300 DCBPDWP BIO-300 Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + BIO-300 DCJDGFG BIO-300 Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + BIO-300 DCHJHEU BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + BIO-300 DCT80CC BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + BIO-300 DCCMCPF BIO-300 Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + BIO-300 DCSDS32 BIO-300 Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + BIO-300 DC72CT0 BIO-300 Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + BIO-300 DCHOEY1 BIO-300 Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + BIO-300 DCWA9WR BIO-300 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + BIO-300 DCFFW46 BIO-300 Prostate carcinoma (Cell Line: PC-3) [4]
ABIRATERONE + Altretamine DCMMR10 Altretamine Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + Altretamine DCLT3EP Altretamine Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Altretamine DCLS1J1 Altretamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Altretamine DCAM5NP Altretamine Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Altretamine DC8VMH9 Altretamine Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + TEM DCDH8D0 TEM Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + TEM DCYW02H TEM Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
ABIRATERONE + TEM DCFC1A9 TEM Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + TEM DC8AUSH TEM Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + JNK-IN-8 DCJSKRE JNK-IN-8 Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + JNK-IN-8 DCDUDM8 JNK-IN-8 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
ABIRATERONE + Idarubicin DCWIRS1 Idarubicin Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Idarubicin DCTIXQL Idarubicin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Indazole derivative 5 DC7QNJW Indazole derivative 5 Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Indazole derivative 5 DCNNQHL Indazole derivative 5 Adenocarcinoma (Cell Line: NCIH23) [4]
ABIRATERONE + Indazole derivative 5 DCWLZZW Indazole derivative 5 Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + Indazole derivative 5 DCAOS0W Indazole derivative 5 Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Indazole derivative 5 DC9F1R4 Indazole derivative 5 Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Indazole derivative 5 DCHFFFZ Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
ABIRATERONE + Indazole derivative 5 DCCJLTZ Indazole derivative 5 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Indazole derivative 5 DCEWESD Indazole derivative 5 Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Indazole derivative 5 DC1W04T Indazole derivative 5 Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Indazole derivative 5 DCI54IX Indazole derivative 5 Melanoma (Cell Line: UACC-257) [4]
ABIRATERONE + Indazole derivative 5 DCONUQQ Indazole derivative 5 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Indazole derivative 5 DCRUCY9 Indazole derivative 5 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Imatinib DCXHJKD Imatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Imatinib DCYFODK Imatinib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Imatinib DC99V1S Imatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Imatinib DCRZQ3K Imatinib Prostate carcinoma (Cell Line: PC-3) [4]
ABIRATERONE + Bleomycin DC3CFQF Bleomycin Adenocarcinoma (Cell Line: A549) [4]
ABIRATERONE + Bleomycin DCAF16T Bleomycin Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + Bleomycin DCJYGVE Bleomycin Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Bleomycin DC63V5E Bleomycin Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Bleomycin DCJG2Q8 Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Bleomycin DCXATRV Bleomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Bleomycin DC8PP1Y Bleomycin Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Bleomycin DC53PYK Bleomycin Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Bleomycin DCROH9S Bleomycin Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Bleomycin DCJW50F Bleomycin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Bleomycin DC0V6B6 Bleomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Bortezomib DCEHA35 Bortezomib Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Bortezomib DCXDZ86 Bortezomib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Anastrozole DCJFX45 Anastrozole Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Anastrozole DCGZT5P Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Anastrozole DC9SQBW Anastrozole Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + Dacarbazine DCF214I Dacarbazine Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Dacarbazine DCKVJ9J Dacarbazine Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Dacarbazine DCTT1ES Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Dacarbazine DCT0MSE Dacarbazine Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Valrubicin DCS4PZB Valrubicin Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Valrubicin DC5C4QB Valrubicin Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Valrubicin DCJFLO7 Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Valrubicin DC9KBDJ Valrubicin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Valrubicin DCUZ63L Valrubicin Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Topotecan DCKU0HV Topotecan Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Topotecan DCQJ5Z7 Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Topotecan DCSKQUX Topotecan Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Topotecan DCLA0LL Topotecan Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Topotecan DCSG4KC Topotecan Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + Topotecan DC68RAI Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Topotecan DCYWTIV Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Topotecan DCLU4IU Topotecan Prostate carcinoma (Cell Line: PC-3) [4]
ABIRATERONE + Cabazitaxel DCX8C1Z Cabazitaxel Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Cabazitaxel DC51U2B Cabazitaxel Adenocarcinoma (Cell Line: A549) [4]
ABIRATERONE + Cabazitaxel DCXP0I1 Cabazitaxel Adenocarcinoma (Cell Line: NCIH23) [4]
ABIRATERONE + Cabazitaxel DC00OAE Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Cabazitaxel DCO9NVH Cabazitaxel Adenocarcinoma (Cell Line: HCC-2998) [4]
ABIRATERONE + Cabazitaxel DCPUG5X Cabazitaxel Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + Cabazitaxel DC5CI13 Cabazitaxel Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Cabazitaxel DCG7RRX Cabazitaxel Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + Cabazitaxel DCZZYID Cabazitaxel Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Cabazitaxel DCV9CDH Cabazitaxel Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Cabazitaxel DCC2JR4 Cabazitaxel Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Cabazitaxel DC1FWX5 Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Cabazitaxel DCCGPJR Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
ABIRATERONE + Cabazitaxel DCUWW58 Cabazitaxel Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Cabazitaxel DCC54ZT Cabazitaxel Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Cabazitaxel DC0QPLD Cabazitaxel Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Cabazitaxel DCJUU05 Cabazitaxel Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + Cabazitaxel DCP2OCJ Cabazitaxel Melanoma (Cell Line: UACC-257) [4]
ABIRATERONE + Cabazitaxel DC4YO2T Cabazitaxel Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + Epirubicin DCRHR4Z Epirubicin Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Epirubicin DCYCF1L Epirubicin Adenocarcinoma (Cell Line: A549) [4]
ABIRATERONE + Epirubicin DCAVXZV Epirubicin Adenocarcinoma (Cell Line: NCIH23) [4]
ABIRATERONE + Epirubicin DCYSTSD Epirubicin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
ABIRATERONE + Epirubicin DC9K1UM Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Epirubicin DCLG7D4 Epirubicin Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Epirubicin DC8ULBU Epirubicin Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Epirubicin DCBDAKJ Epirubicin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Epirubicin DCRNCUL Epirubicin Malignant melanoma (Cell Line: UACC62) [4]
ABIRATERONE + Epirubicin DCKH16Q Epirubicin Melanoma (Cell Line: UACC-257) [4]
ABIRATERONE + Epirubicin DC99MB4 Epirubicin Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Epirubicin DC8TFT4 Epirubicin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Epirubicin DC4J8UD Epirubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Cisplatin DCRFIB7 Cisplatin Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Cisplatin DCZGJMR Cisplatin Malignant melanoma (Cell Line: UACC62) [4]
ABIRATERONE + Cisplatin DCH5HNF Cisplatin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Cisplatin DC9LCDA Cisplatin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Vandetanib DCCGAO0 Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Vandetanib DCY85DZ Vandetanib Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Vandetanib DCVMT8A Vandetanib Melanoma (Cell Line: UACC-257) [4]
ABIRATERONE + Chlorambucil DCLNFHW Chlorambucil Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Chlorambucil DCONF5A Chlorambucil Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + ER819762 DCLO1KI ER819762 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + ER819762 DCBILKQ ER819762 Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + ER819762 DCX1AZ6 ER819762 Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Romidepsin DCR5DNE Romidepsin Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Romidepsin DC5HPJ3 Romidepsin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Azacitidine DC768PH Azacitidine Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Azacitidine DC7029O Azacitidine Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Azacitidine DCXOVXN Azacitidine Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Pomalidomide DC2R0OY Pomalidomide Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
ABIRATERONE + Pomalidomide DCY52QI Pomalidomide Lung adenocarcinoma (Cell Line: EKVX) [4]
ABIRATERONE + Pomalidomide DC3S7MU Pomalidomide Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
ABIRATERONE + Vinflunine DCR6EP8 Vinflunine Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Vinflunine DCTYQ2D Vinflunine Adenocarcinoma (Cell Line: NCIH23) [4]
ABIRATERONE + Vinflunine DCTG0NG Vinflunine Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Vinflunine DCR8ASR Vinflunine Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Vinflunine DCRDCYK Vinflunine Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Mercaptopurine DCIJJ5B Mercaptopurine Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Mercaptopurine DC3DT7I Mercaptopurine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Taxol DCBXX2Y Taxol Adenocarcinoma (Cell Line: OVCAR3) [4]
ABIRATERONE + Taxol DC9AXO9 Taxol Adenocarcinoma (Cell Line: A549) [4]
ABIRATERONE + Taxol DC8FO7S Taxol Adenocarcinoma (Cell Line: SW-620) [4]
ABIRATERONE + Taxol DCTZV6G Taxol Adenocarcinoma (Cell Line: HCT116) [4]
ABIRATERONE + Taxol DC6X86K Taxol Adenocarcinoma (Cell Line: HCT-15) [4]
ABIRATERONE + Taxol DCGX9OK Taxol Adenocarcinoma (Cell Line: HCC-2998) [4]
ABIRATERONE + Taxol DCCLVLM Taxol Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Taxol DCXBDK2 Taxol Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Taxol DCSLWNE Taxol Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Taxol DCFKLXA Taxol Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Taxol DCVPQMO Taxol High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
ABIRATERONE + Taxol DCUM32Y Taxol Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Taxol DCQXIZ0 Taxol Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Taxol DCK0Q71 Taxol Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Taxol DC0GFIV Taxol Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + Taxol DCLZ8J5 Taxol Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Taxol DCJ5QOS Taxol Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + Fludarabine DCY28A3 Fludarabine Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Fludarabine DCT73GU Fludarabine Melanoma (Cell Line: MALME-3M) [4]
ABIRATERONE + PMID28870136-Compound-43 DCT94H7 PMID28870136-Compound-43 Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
ABIRATERONE + PMID28870136-Compound-43 DCF0FQX PMID28870136-Compound-43 Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + FORMESTANE DCPJS9Y FORMESTANE Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + FORMESTANE DC7A5SR FORMESTANE Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + FORMESTANE DCEUZ17 FORMESTANE Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + FORMESTANE DCGUEEI FORMESTANE Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Aminolevulinic Acid Hydrochloride DCU5GH5 Aminolevulinic Acid Hydrochloride Malignant melanoma (Cell Line: UACC62) [4]
ABIRATERONE + Aminolevulinic Acid Hydrochloride DCMOKH0 Aminolevulinic Acid Hydrochloride Melanoma (Cell Line: SK-MEL-2) [4]
ABIRATERONE + Estramustine DCE28KY Estramustine Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Estramustine DCAYMWR Estramustine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Estramustine DC6H2XZ Estramustine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Estramustine DCNDTJL Estramustine Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Digitoxin DC135N2 Digitoxin Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Digitoxin DCWWV3F Digitoxin Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Digitoxin DC5OZXB Digitoxin Melanoma (Cell Line: UACC-257) [4]
ABIRATERONE + Digitoxin DC4C1TV Digitoxin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + Dasatinib DC5T2QO Dasatinib Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Dasatinib DCUJ17B Dasatinib Adenocarcinoma (Cell Line: HT29) [4]
ABIRATERONE + Dasatinib DC992H0 Dasatinib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Dasatinib DCLRBVI Dasatinib Lung adenocarcinoma (Cell Line: HOP-62) [4]
ABIRATERONE + Dasatinib DCH4WFX Dasatinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
ABIRATERONE + Dasatinib DCNZLTP Dasatinib Lung adenocarcinoma (Cell Line: NCI-H522) [4]
ABIRATERONE + Dasatinib DC0N8BQ Dasatinib Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Dasatinib DCTM26L Dasatinib Malignant melanoma (Cell Line: UACC62) [4]
ABIRATERONE + Dasatinib DC6WEI5 Dasatinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
ABIRATERONE + Dasatinib DCZX0HM Dasatinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
ABIRATERONE + Dasatinib DCKA165 Dasatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
ABIRATERONE + Dasatinib DCYM2V2 Dasatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
ABIRATERONE + Dasatinib DCTLQXQ Dasatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
ABIRATERONE + Dasatinib DCI80OH Dasatinib Prostate carcinoma (Cell Line: PC-3) [4]
Cabazitaxel + ABIRATERONE DCYIDLH Cabazitaxel Adenocarcinoma (Cell Line: NCIH23) [2]
Cabazitaxel + ABIRATERONE DCCB8NU Cabazitaxel Adenocarcinoma (Cell Line: SW-620) [2]
Cabazitaxel + ABIRATERONE DCZXGLB Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [2]
Cabazitaxel + ABIRATERONE DCT200A Cabazitaxel Adenocarcinoma (Cell Line: HCC-2998) [2]
Cabazitaxel + ABIRATERONE DCXPVJO Cabazitaxel Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Cabazitaxel + ABIRATERONE DCAZSGX Cabazitaxel Amelanotic melanoma (Cell Line: M14) [2]
Cabazitaxel + ABIRATERONE DCXQMN5 Cabazitaxel Astrocytoma (Cell Line: U251) [2]
Cabazitaxel + ABIRATERONE DCDZAKB Cabazitaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Cabazitaxel + ABIRATERONE DC6ZX9I Cabazitaxel Chronic myelogenous leukemia (Cell Line: K-562) [2]
Cabazitaxel + ABIRATERONE DCCI7CX Cabazitaxel Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Cabazitaxel + ABIRATERONE DCJPYCN Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Cabazitaxel + ABIRATERONE DC4RJLS Cabazitaxel Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Cabazitaxel + ABIRATERONE DCI3O6Z Cabazitaxel Glioma (Cell Line: SF-539) [2]
Cabazitaxel + ABIRATERONE DCPLFKR Cabazitaxel Glioma (Cell Line: SF-268) [2]
Cabazitaxel + ABIRATERONE DCFEPRS Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Cabazitaxel + ABIRATERONE DCH95OO Cabazitaxel Lung adenocarcinoma (Cell Line: HOP-62) [2]
Cabazitaxel + ABIRATERONE DCDP000 Cabazitaxel Malignant melanoma (Cell Line: LOX IMVI) [2]
Cabazitaxel + ABIRATERONE DCMEVCL Cabazitaxel Melanoma (Cell Line: UACC-257) [2]
Cabazitaxel + ABIRATERONE DCPYRRY Cabazitaxel Melanoma (Cell Line: MALME-3M) [2]
Cabazitaxel + ABIRATERONE DCC013U Cabazitaxel Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Cabazitaxel + ABIRATERONE DCDXLIA Cabazitaxel Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Cabazitaxel + ABIRATERONE DCA3ZES Cabazitaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Cabazitaxel + ABIRATERONE DCN7AIM Cabazitaxel Carcinoma (Cell Line: MCF7) [3]
Crizotinib + ABIRATERONE DCF3O28 Crizotinib Adenocarcinoma (Cell Line: OVCAR3) [2]
Crizotinib + ABIRATERONE DCQ49CZ Crizotinib Adenocarcinoma (Cell Line: NCIH23) [2]
Crizotinib + ABIRATERONE DCX83L8 Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Crizotinib + ABIRATERONE DC18ZQC Crizotinib Amelanotic melanoma (Cell Line: M14) [2]
Crizotinib + ABIRATERONE DC3PJU8 Crizotinib Astrocytoma (Cell Line: U251) [2]
Crizotinib + ABIRATERONE DCDRP14 Crizotinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Crizotinib + ABIRATERONE DCK5EF4 Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Crizotinib + ABIRATERONE DCZKZ2R Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Crizotinib + ABIRATERONE DCWKTT7 Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Crizotinib + ABIRATERONE DC05H9W Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Crizotinib + ABIRATERONE DC8DTBE Crizotinib Lung adenocarcinoma (Cell Line: HOP-62) [2]
Crizotinib + ABIRATERONE DC2N56W Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [2]
Crizotinib + ABIRATERONE DCYIZHJ Crizotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Crizotinib + ABIRATERONE DCJLE5H Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Crizotinib + ABIRATERONE DCYD2VV Crizotinib Invasive ductal carcinoma (Cell Line: BT-549) [3]
Epirubicin + ABIRATERONE DCMPZ0G Epirubicin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Epirubicin + ABIRATERONE DCWPOH4 Epirubicin Astrocytoma (Cell Line: U251) [2]
Epirubicin + ABIRATERONE DCQZQ2S Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Epirubicin + ABIRATERONE DC6OOIS Epirubicin Glioma (Cell Line: SF-539) [2]
Epirubicin + ABIRATERONE DCSD7GF Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Epirubicin + ABIRATERONE DCD3HXM Epirubicin Renal cell carcinoma (Cell Line: UO-31) [2]
Epirubicin + ABIRATERONE DC5UHDR Epirubicin Colon adenocarcinoma (Cell Line: COLO 205) [3]
Epirubicin + ABIRATERONE DC9US4R Epirubicin Colon carcinoma (Cell Line: KM12) [3]
Epirubicin + ABIRATERONE DC0SO6P Epirubicin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Epirubicin + ABIRATERONE DCSDCOA Epirubicin Adenocarcinoma (Cell Line: DU-145) [4]
Epirubicin + ABIRATERONE DC0BC7O Epirubicin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Epirubicin + ABIRATERONE DCZCUTV Epirubicin Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Epirubicin + ABIRATERONE DCSCXLM Epirubicin Lung adenocarcinoma (Cell Line: EKVX) [4]
Epirubicin + ABIRATERONE DC2T7YQ Epirubicin Malignant melanoma (Cell Line: UACC62) [4]
Epirubicin + ABIRATERONE DCZGKK3 Epirubicin Melanoma (Cell Line: SK-MEL-2) [4]
Epirubicin + ABIRATERONE DCPSWIZ Epirubicin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Epirubicin + ABIRATERONE DC4V8VU Epirubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Indazole derivative 5 + ABIRATERONE DCRCGB2 Indazole derivative 5 Glioma (Cell Line: SF-539) [2]
Indazole derivative 5 + ABIRATERONE DCKEH6T Indazole derivative 5 Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Indazole derivative 5 + ABIRATERONE DCZLSL4 Indazole derivative 5 Colon adenocarcinoma (Cell Line: COLO 205) [3]
Indazole derivative 5 + ABIRATERONE DCIOSIR Indazole derivative 5 Adenocarcinoma (Cell Line: DU-145) [4]
Indazole derivative 5 + ABIRATERONE DCVUN1Q Indazole derivative 5 Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Indazole derivative 5 + ABIRATERONE DCHXB5F Indazole derivative 5 Lung adenocarcinoma (Cell Line: HOP-62) [4]
Indazole derivative 5 + ABIRATERONE DCSY3UG Indazole derivative 5 Melanoma (Cell Line: SK-MEL-2) [4]
Indazole derivative 5 + ABIRATERONE DCJRXF3 Indazole derivative 5 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Raloxifene + ABIRATERONE DC912R2 Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Raloxifene + ABIRATERONE DCOQX8F Raloxifene Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Raloxifene + ABIRATERONE DCGRV3P Raloxifene Glioma (Cell Line: SF-268) [2]
Raloxifene + ABIRATERONE DCRGI3J Raloxifene Invasive ductal carcinoma (Cell Line: BT-549) [3]
Raloxifene + ABIRATERONE DCB8E1W Raloxifene Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Raloxifene + ABIRATERONE DCD8BQ5 Raloxifene Adenocarcinoma (Cell Line: DU-145) [4]
Raloxifene + ABIRATERONE DCMT2AD Raloxifene Adenocarcinoma (Cell Line: NCIH23) [4]
Raloxifene + ABIRATERONE DCRMYLN Raloxifene Adenocarcinoma (Cell Line: HCT-15) [4]
Raloxifene + ABIRATERONE DC984Q1 Raloxifene Amelanotic melanoma (Cell Line: M14) [4]
Raloxifene + ABIRATERONE DCTLHNA Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Raloxifene + ABIRATERONE DCUFUBS Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Raloxifene + ABIRATERONE DC2XQJD Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Raloxifene + ABIRATERONE DC9PAV8 Raloxifene Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Raloxifene + ABIRATERONE DCPCYMR Raloxifene Malignant melanoma (Cell Line: UACC62) [4]
Raloxifene + ABIRATERONE DC2IW26 Raloxifene Melanoma (Cell Line: SK-MEL-2) [4]
Raloxifene + ABIRATERONE DCM2JTD Raloxifene Prostate carcinoma (Cell Line: PC-3) [4]
Ruxolitinib + ABIRATERONE DCMRNHR Ruxolitinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Ruxolitinib + ABIRATERONE DCZ8OOY Ruxolitinib Carcinoma (Cell Line: MCF7) [3]
Ruxolitinib + ABIRATERONE DC3T7HM Ruxolitinib Colon adenocarcinoma (Cell Line: COLO 205) [3]
Ruxolitinib + ABIRATERONE DC210W4 Ruxolitinib Invasive ductal carcinoma (Cell Line: BT-549) [3]
Ruxolitinib + ABIRATERONE DC5Q424 Ruxolitinib Adenocarcinoma (Cell Line: DU-145) [4]
Ruxolitinib + ABIRATERONE DCEO8Q7 Ruxolitinib Adenocarcinoma (Cell Line: SW-620) [4]
Ruxolitinib + ABIRATERONE DC5RX20 Ruxolitinib Melanoma (Cell Line: SK-MEL-2) [4]
Ruxolitinib + ABIRATERONE DCXX68P Ruxolitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Vandetanib + ABIRATERONE DCZBK7S Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Vandetanib + ABIRATERONE DCMIGPZ Vandetanib Colon adenocarcinoma (Cell Line: COLO 205) [3]
Vandetanib + ABIRATERONE DCFLRD3 Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [3]
Vandetanib + ABIRATERONE DCCB80Z Vandetanib Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Vandetanib + ABIRATERONE DC59VPU Vandetanib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vandetanib + ABIRATERONE DCJHAV6 Vandetanib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vandetanib + ABIRATERONE DCMY0L9 Vandetanib Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Vandetanib + ABIRATERONE DCT741H Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Vandetanib + ABIRATERONE DCPBGJP Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Vandetanib + ABIRATERONE DCRSUFZ Vandetanib Melanoma (Cell Line: UACC-257) [4]
Vandetanib + ABIRATERONE DC80HS3 Vandetanib Melanoma (Cell Line: SK-MEL-2) [4]
Vemurafenib + ABIRATERONE DCWQ0R0 Vemurafenib Invasive ductal carcinoma (Cell Line: BT-549) [3]
Vemurafenib + ABIRATERONE DCAJTSY Vemurafenib Adenocarcinoma (Cell Line: DU-145) [4]
Vemurafenib + ABIRATERONE DCV2PB9 Vemurafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vemurafenib + ABIRATERONE DC8I94F Vemurafenib Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Vemurafenib + ABIRATERONE DCTYFNK Vemurafenib Amelanotic melanoma (Cell Line: M14) [4]
Vemurafenib + ABIRATERONE DCYVLAV Vemurafenib Astrocytoma (Cell Line: U251) [4]
Vemurafenib + ABIRATERONE DCGVOWP Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vemurafenib + ABIRATERONE DCK3NJS Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Vemurafenib + ABIRATERONE DCO07YW Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Vemurafenib + ABIRATERONE DCENWUQ Vemurafenib Glioblastoma (Cell Line: SNB-75) [4]
Vemurafenib + ABIRATERONE DCJV67P Vemurafenib Melanoma (Cell Line: MALME-3M) [4]
Vemurafenib + ABIRATERONE DC8L4QU Vemurafenib Melanoma (Cell Line: UACC-257) [4]
Vemurafenib + ABIRATERONE DCUG9EQ Vemurafenib Melanoma (Cell Line: SK-MEL-2) [4]
Vemurafenib + ABIRATERONE DCA6DAM Vemurafenib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Vemurafenib + ABIRATERONE DCZSFXT Vemurafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Vismodegib + ABIRATERONE DC3DQ5U Vismodegib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Vismodegib + ABIRATERONE DCRU67X Vismodegib Colon adenocarcinoma (Cell Line: COLO 205) [3]
Vismodegib + ABIRATERONE DC45HWA Vismodegib Invasive ductal carcinoma (Cell Line: BT-549) [3]
Vismodegib + ABIRATERONE DCIWNKI Vismodegib Adenocarcinoma (Cell Line: DU-145) [4]
Vismodegib + ABIRATERONE DCG7BNI Vismodegib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vismodegib + ABIRATERONE DCPPUUW Vismodegib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vismodegib + ABIRATERONE DCYMDM9 Vismodegib Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Vismodegib + ABIRATERONE DC2DGSI Vismodegib Glioblastoma (Cell Line: SNB-75) [4]
Vismodegib + ABIRATERONE DCGJQBO Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [4]
Vismodegib + ABIRATERONE DCA2YEA Vismodegib Melanoma (Cell Line: SK-MEL-2) [4]
Vismodegib + ABIRATERONE DCJUPNU Vismodegib Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Vismodegib + ABIRATERONE DCQLJ9L Vismodegib Renal cell carcinoma (Cell Line: UO-31) [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 997 DrugCom(s)
29 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Cabozantinib DC7GQU9 Cabozantinib Prostate Cancer [5]
ABIRATERONE + Prednisolone DCIP21R Prednisolone Prostate Cancer [6]
ABIRATERONE + Prednisone DCTT9F0 Prednisone Hormone-Resistant Prostate Cancer [7]
ABIRATERONE + LY2835219 DCLEBJ0 LY2835219 Advanced Cancer [8]
ABIRATERONE + Onapristone DCHLJ9E Onapristone Prostate Cancer [9]
ABIRATERONE + AZD5363 DCSEXOP AZD5363 Prostate Cancer [10]
Leuprolide + ABIRATERONE DCC5P8T Leuprolide Prostate Cancer [11]
ABIRATERONE + Enzalutamide DC4OUBQ Enzalutamide Castration-Resistant Prostate Carcinoma [12]
ABIRATERONE + Goserelin DC6G14H Goserelin Prostate Cancer [13]
ABIRATERONE + ABT-263 DC7NFUT ABT-263 Prostate Cancer [14]
ABIRATERONE + Prednisone DC81FZT Prednisone Castration Levels of Testosterone [15]
ABIRATERONE + Hydrocortisone DCMLYR0 Hydrocortisone Congenital Adrenal Hyperplasia [16]
ABIRATERONE + Goserelin DCQE28F Goserelin Prostate Cancer [17]
ABIRATERONE + Niclosamide DCRFN2Y Niclosamide Metastatic Prostate Carcinoma [18]
ABIRATERONE + Arn-509 DC1MW8P Arn-509 Prostatic Neoplasms, Castration-Resistant [19]
ABIRATERONE + ABT-263 DC2J02L ABT-263 Prostate Cancer [14]
ABIRATERONE + Dutasteride DCECZF8 Dutasteride Prostate Cancer [20]
ABIRATERONE + Enzalutamide DCH6TA6 Enzalutamide Prostate Cancer Metastatic [21]
ABIRATERONE + Enzalutamide DCH6TE3 Enzalutamide Prostatic Neoplasms, Castration-Resistant [22]
ABIRATERONE + Enzalutamide DCYXMPV Enzalutamide Metastatic Castration-Resistant Prostatic Cancer [23]
Dexamethasone + ABIRATERONE DCJYFWW Dexamethasone Prostate Cancer [24]
Leuprolide + ABIRATERONE DCLJJZL Leuprolide Prostate Cancer [25]
Leuprolide + ABIRATERONE DCHM8XH Leuprolide Prostate Cancer [26]
Leuprolide + ABIRATERONE DCWFB6E Leuprolide Newly Diagnosed Oligometastatic Prostate Cancer [27]
ABIRATERONE + ABIRATERONE DCZX54P ABIRATERONE Metastatic Castration-resistant Prostate Cancer [28]
ABIRATERONE + Docetaxel DCDPHIL Docetaxel Metastatic Prostate Cancer [29]
ABIRATERONE + Enzalutamide DCOODJK Enzalutamide Metastatic Castration-resistant Prostate Cancer (mCRPC) [30]
Olaparib + ABIRATERONE DC8UOFZ Olaparib Metastatic Castration-resistant Prostate Cancer [31]
ABIRATERONE + Enzalutamide DC51IJ4 Enzalutamide Prostate Cancer [32]
------------------------------------------------------------------------------------
⏷ Show the Full List of 29 DrugCom(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6745).
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
4 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
5 ClinicalTrials.gov (NCT01574937) XL-184+Abiraterone in Post-Chemo CRPC
6 ClinicalTrials.gov (NCT01685983) A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer
7 ClinicalTrials.gov (NCT01503229) Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
8 ClinicalTrials.gov (NCT04071262) A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer
9 ClinicalTrials.gov (NCT02049190) Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
10 ClinicalTrials.gov (NCT04087174) A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer
11 ClinicalTrials.gov (NCT04194554) A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
12 ClinicalTrials.gov (NCT03999515) Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer
13 ClinicalTrials.gov (NCT02867020) Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
14 ClinicalTrials.gov (NCT01828476) Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer
15 ClinicalTrials.gov (NCT02703623) Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
16 ClinicalTrials.gov (NCT03548246) Androgen Reduction in Congenital Adrenal Hyperplasia
17 ClinicalTrials.gov (NCT04736108) Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate
18 ClinicalTrials.gov (NCT02807805) Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
19 ClinicalTrials.gov (NCT03173859) Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients
20 ClinicalTrials.gov (NCT05705700) Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)
21 ClinicalTrials.gov (NCT03295565) Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel
22 ClinicalTrials.gov (NCT05393791) Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
23 ClinicalTrials.gov (NCT02254785) Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer
24 ClinicalTrials.gov (NCT01867710) Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy
25 ClinicalTrials.gov (NCT03043807) A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
26 ClinicalTrials.gov (NCT02772588) AASUR in High Risk Prostate Cancer
27 ClinicalTrials.gov (NCT03298087) Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
28 ClinicalTrials.gov (NCT02987543) Study of Olaparib (Lynparza? Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
29 ClinicalTrials.gov (NCT01957436) A Phase III Study for Patients With Metastatic Hormone-nave Prostate Cancer
30 ClinicalTrials.gov (NCT06136650) A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
31 ClinicalTrials.gov (NCT05171816) Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)
32 ClinicalTrials.gov (NCT01995513) Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients